Sarepta Therapeutics Inc (NASDAQ:SRPT)
| 23.49 Real-Time Quote |  +3.16 / +15.54%Today’s Change | 12.12 Today|||52-Week Range 55.61 | +15.32% Year-to-Date |
Stock Price Forecast
The 13 analysts offering 12-month price forecasts for Sarepta Therapeutics Inc have a median target of 37.00, with a high estimate of 63.00 and a low estimate of 13.00. The median estimate represents a +57.51% increase from the last price of 23.49.
Analyst Recommendations
The current consensus among 15 polled investment analysts is to Buy stock in Sarepta Therapeutics Inc. This rating has held steady since July, when it was unchanged from a rating.Move your mouse over past
months for detail
Earnings and Sales Forecasts
Current Quarter
Earnings per Share
-$0.77
-$0.77
Sales
$4.1M
$4.1M
Reporting Date
Aug 11
Aug 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.
Growthquarterly -2.19%
Growthannually 4.70%
Sales
Growthquarterly -32.16%
Growthannually 28.83%
.
